{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:51Z","timestamp":1783416351520,"version":"3.54.6"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cholesterol metabolism is critical in cancer biology, yet its role in hepatocellular carcinoma (HCC) remains poorly understood. We investigated the expression and prognostic significance of cholesterol homeostasis genes in HCC to identify potential biomarkers for risk stratification. Using data from The Cancer Genome Atlas, we identified differentially expressed cholesterol-related genes (logFC\u2005\u2265\u20051.5, false discovery rate\u2005&lt;\u20050.05), intersecting them with genes annotated in the Molecular Signatures Database. Prognostic biomarkers were evaluated using univariate and multivariate Cox regression. A predictive model was constructed to assess survival outcomes. Cholesterol homeostasis genes, particularly fatty acid-binding protein 5 (FABP5) and alcohol dehydrogenase 4 (ADH4), are key prognostic biomarkers in HCC. The proposed model provides a novel approach for predicting outcomes and may inform therapeutic strategies. Further studies are needed to validate these findings and explore their clinical utility. Nine cholesterol homeostasis genes were differentially expressed, including 6 upregulated (choline kinase alpha, FABP5, fatty acid synthase, farnesyl diphosphate synthase, mevalonate diphosphate decarboxylase, and squalene epoxidase) and 3 downregulated (ADH4, activating transcription factor 5, and arginine vasopressin receptor 1A). FABP5 and ADH4 emerged as independent prognostic factors: high FABP5 expression was associated with poor prognosis, while high ADH4 expression predicted improved survival. A prognostic model integrating FABP5 and ADH4 and clinical characteristics achieved a concordance index of 0.683, effectively stratifying patients into high-risk and low-risk groups (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200520.60,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) with median survival times of 1135 and 2532 days, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048547","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:56Z","timestamp":1779469256000},"page":"e48547","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Expression and prognostic value of cholesterol homeostasis genes in hepatocellular carcinoma: A cohort study based on TCGA"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-1162","authenticated-orcid":false,"given":"Chongyu","family":"Ding","sequence":"first","affiliation":[{"name":"School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Huo","sequence":"additional","affiliation":[{"name":"School of Public Health and Management, Jiangsu Medical College, Jiangsu, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qian","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Gong","sequence":"additional","affiliation":[{"name":"School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darong","family":"Hao","sequence":"additional","affiliation":[{"name":"School of Global Health, Chinese Centre for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5859-4686","authenticated-orcid":false,"given":"Dan","family":"Meng","sequence":"additional","affiliation":[{"name":"Community Health Service Center of Haiwan Town, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management.","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis.","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"682911","DOI":"10.3389\/fonc.2021.682911","article-title":"Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy.","volume":"11","author":"Giacomini","year":"2021","journal-title":"Front Oncol"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer.","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/cncr.31257","article-title":"Molecular signatures in hepatocellular carcinoma: a step toward rationally designed cancer therapy.","volume":"124","author":"Erstad","year":"2018","journal-title":"Cancer"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection.","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1002\/imt2.238","article-title":"Sangerbox 2: enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform.","volume":"3","author":"Chen","year":"2024","journal-title":"Imeta"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.lungcan.2020.09.014","article-title":"Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: a comprehensive analysis based on TCGA and GEO databases.","volume":"149","author":"Zhao","year":"2020","journal-title":"Lung Cancer"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.drudis.2023.103628","article-title":"The emerging role of fatty acid binding protein 5 (FABP5) in cancers.","volume":"28","author":"George Warren","year":"2023","journal-title":"Drug Discov Today"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"eaap9840","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.","volume":"10","author":"Liu","year":"2018","journal-title":"Sci Transl Med"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1053\/j.gastro.2016.12.033","article-title":"Choline kinase \u03b1 mediates interactions between the epidermal growth factor receptor and mechanistic target of rapamycin complex 2 in hepatocellular carcinoma cells to promote drug resistance and xenograft tumor progression.","volume":"152","author":"Lin","year":"2017","journal-title":"Gastroenterology"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1007\/s13277-015-3301-x","article-title":"Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.","volume":"36","author":"Sui","year":"2015","journal-title":"Tumour Biol"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s12032-011-0126-3","article-title":"Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.","volume":"29","author":"Wei","year":"2012","journal-title":"Med Oncol"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/CCI.21.00094","article-title":"Novel insight into the association between obesity and hepatocellular carcinoma occurrence and recurrence: high-throughput microarray data set analysis of differentially expressed genes.","volume":"5","author":"Hassani","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"R19-20260707","first-page":"219","article-title":"The role of cholesterol metabolism in cancer.","volume":"9","author":"Ding","year":"2019","journal-title":"Am J Cancer Res"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.medici.2016.03.002","article-title":"Hypertension, serum lipids and cancer risk: a review of epidemiological evidence.","volume":"52","author":"Radisauskas","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/hsz-2014-0194","article-title":"Cholesterol lowering: role in cancer prevention and treatment.","volume":"396","author":"Murai","year":"2015","journal-title":"Biol Chem"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.nutres.2016.04.009","article-title":"Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer.","volume":"36","author":"Li","year":"2016","journal-title":"Nutr Res"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer.","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2016.02.017","article-title":"Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome.","volume":"105","author":"Du","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.18632\/oncotarget.3476","article-title":"Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1.","volume":"6","author":"Moon","year":"2015","journal-title":"Oncotarget"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1038\/s41467-018-06931-6","article-title":"Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling.","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"e7819","DOI":"10.1371\/journal.pone.0007819","article-title":"Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.","volume":"4","author":"Gallego-Ortega","year":"2009","journal-title":"PLoS One"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/oncsis.2013.2","article-title":"A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.","volume":"2","author":"Falcon","year":"2013","journal-title":"Oncogenesis"},{"key":"R29-20260707","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1097\/JS9.0000000000003049","article-title":"Fatty acid-binding proteins in cancers.","volume":"111","author":"Wu","year":"2025","journal-title":"Int J Surg"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","article-title":"Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells.","volume":"3","author":"Seo","year":"2020","journal-title":"Commun Biol"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biopha.2018.06.040","article-title":"Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6\/STAT3\/VEGFA pathway in hepatocellular carcinoma.","volume":"106","author":"Pan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R32-20260707","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cam4.1020","article-title":"Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.","volume":"6","author":"Ohata","year":"2017","journal-title":"Cancer Med"},{"key":"R33-20260707","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1186\/s12885-020-07689-1","article-title":"Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma.","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:01:06Z","timestamp":1783414866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048547","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}